Modulation of HIV-1 epitranscriptome: A novel approach to improve "shock & kill" therapy.
2022/45/N/NZ6/04203
Keywords
Descriptors
- NZ6_005: Wirusologia
- NZ2_002: Genomika, transkryptomika i epigenomika
- NZ7_014: Farmacja, farmakoterapia, farmakologia
Panel
NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution
Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego
Voivodeship: małopolskie
Principal investigator (from the host institution)
Haider Ali brak danych (PI has only a Name - in accordance with PESEL)
Number of co-investigators in the project: 2
Call
PRELUDIUM 21 – announced on 2022-03-28
- Amount awarded
- 139 739 PLN
- Project start date
- 2023-02-17
- Project end date
- 2025-12-16
- Project duration
- 34 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.